BUDGET IMPACT OF NEWLY APPROVED DRUGS BY THE SICILIAN DRUG FORMULARY COMMITTEE: AN INTRODUCTIVE ANALYSIS

被引:0
|
作者
Aiello, A. [1 ]
D'Ausilio, A. [1 ]
Pizzimenti, V [2 ]
Formica, D. [2 ]
Sultana, J. [2 ]
Lucchesi, S. [3 ]
Ientile, V [2 ]
Toumi, M. [4 ]
Trifiro, G. [3 ]
机构
[1] Creativ Ceut, Milan, Italy
[2] AOU Policlin G Martino, Messina, Italy
[3] Univ Messina, Messina, Italy
[4] Aix Marseille Univ, Marseille, France
关键词
D O I
10.1016/j.jval.2017.08.1631
中图分类号
F [经济];
学科分类号
02 ;
摘要
PHP97
引用
收藏
页码:A669 / A669
页数:1
相关论文
共 50 条
  • [22] Longitudinal trends and subgroup analysis in publication patterns for preclinical data of newly approved drugs
    Koster, Ursula
    Nolte, Ingo
    Michel, Martin C.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (02) : 201 - 209
  • [23] Longitudinal trends and subgroup analysis in publication patterns for preclinical data of newly approved drugs
    Ursula Köster
    Ingo Nolte
    Martin C. Michel
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2016, 389 : 201 - 209
  • [24] TREND ANALYSIS OF LISTING AND BUDGET IMPACT FOR ORPHAN DRUGS IN KOREA
    Kim, Y.
    Oh, R.
    VALUE IN HEALTH, 2017, 20 (09) : A567 - A567
  • [25] Budget Impact Analysis of Diabetes Drugs: A Systematic Literature Review
    Luo, Zejun
    Ruan, Zhen
    Yao, Dongning
    Ung, Carolina Oi Lam
    Lai, Yunfeng
    Hu, Hao
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [26] BUDGET IMPACT ANALYSIS OF ANTIPSYCHOTIC DRUGS IN THE HOSPITAL TREATMENT OF SCHIZOPHRENIA
    Maksimkina, Elena Anatolyevna
    Vaskova, Larisa Borisovna
    Musina, Nuria Zagitovna
    Tiapkina, Marina Vladimirovna
    PERIODICO TCHE QUIMICA, 2019, 16 (32): : 509 - 515
  • [27] DRUG-RELATED PUBLIC EXPENDITURE IN EUROPE: THE BUDGET IMPACT OF ILLEGAL DRUGS
    Prieto, L.
    VALUE IN HEALTH, 2008, 11 (06) : A582 - A582
  • [28] Molecular descriptor analysis of approved drugs using unsupervised learning for drug repurposing
    Madugula, Sita Sirisha
    John, Lijo
    Nagamani, Selvaraman
    Gaur, Anamika Singh
    Poroikov, Vladimir V.
    Sastry, G. Narahari
    COMPUTERS IN BIOLOGY AND MEDICINE, 2021, 138
  • [29] The New Food and Drug Administration Approved Drugs in 2014: a 2015 Report Analysis
    Santos, Wilson C.
    da Silva, Fernando C.
    Pinto, Angelo C.
    Ferreira, Vitor F.
    REVISTA VIRTUAL DE QUIMICA, 2015, 7 (04) : 1535 - 1551
  • [30] The Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer Drugs
    Niraula, Saroj
    Seruga, Bostjan
    Ocana, Alberto
    Shao, Tiffany
    Goldstein, Robyn
    Tannock, Ian F.
    Amir, Eitan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (24) : 3012 - 3019